Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 44,536 | 24,248 | 11,693 | 17,710 | -18,798 |
| Depreciation Amortization | 1,619 | 1,310 | 675 | 2,839 | 2,137 |
| Income taxes - deferred | 2,353 | 2,791 | 2,662 | -1,654 | -9,240 |
| Accounts receivable | -46,648 | -33,435 | -12,495 | 2,227 | 5,330 |
| Accounts payable and accrued liabilities | 1,446 | 565 | -129 | 633 | 2,717 |
| Other Working Capital | -58,942 | -38,860 | -14,699 | 21,970 | 12,182 |
| Other Operating Activity | 56,515 | 40,212 | 16,702 | 8,928 | 1,019 |
| Operating Cash Flow | $879 | $-3,169 | $4,409 | $52,653 | $-4,653 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,358 | -1,256 | -504 | -2,506 | -2,272 |
| Purchase Of Investment | -179,076 | -99,721 | -54,710 | -251,371 | -186,222 |
| Sale Of Investment | 153,981 | 104,986 | 52,766 | 249,305 | 198,823 |
| Investing Cash Flow | $-27,453 | $4,009 | $-2,448 | $-4,572 | $10,329 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -59 | -39 | -19 | -73 | -54 |
| Common Stock Issued | 5,192 | 2,207 | 436 | 1,079 | 266 |
| Other Financing Activity | -1,757 | -1,757 | 0 | 11 | -202 |
| Financing Cash Flow | $3,376 | $411 | $417 | $1,017 | $10 |
| Beginning Cash Position | 66,283 | 66,283 | 66,283 | 17,185 | 16,577 |
| End Cash Position | 43,085 | 67,534 | 68,661 | 66,283 | 22,263 |
| Net Cash Flow | $-23,198 | $1,251 | $2,378 | $49,098 | $5,686 |
| Free Cash Flow | |||||
| Operating Cash Flow | 879 | -3,169 | 4,409 | 52,653 | -4,653 |
| Capital Expenditure | -2,358 | -1,256 | -504 | -2,506 | -2,272 |
| Free Cash Flow | -1,479 | -4,425 | 3,905 | 50,147 | -6,925 |